Hannes Koolman,Wilfried Braje,Helmut Mack,Andreas Haupt,Ana Lucia Relo,Karla Drescher,Margaretha Henrica Maria Bakker,Viktor Lakics,Carolin Hoft,Ruxu Xu,Xiaona Zhao
申请号：
US14026354
公开号：
US10118926B2
申请日:
2013.09.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT2C receptor, and to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT2C receptor.
